NDAOPHTHALMICFOR SUSPENSION
Approved
Dec 1953
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHLOROMYCETIN HYDROCORTISONE is a fixed-dose ophthalmic suspension combining chloramphenicol (a broad-spectrum antibiotic) and hydrocortisone acetate (a corticosteroid) for topical eye use. This combination product treats bacterial eye infections with concurrent inflammation, such as conjunctivitis and blepharitis. The chloramphenicol component inhibits bacterial protein synthesis while hydrocortisone reduces inflammatory response.
LOE Approaching
With LOE approaching and moderate competitive pressure (30%), the brand team is likely in defensive/optimization mode with limited expansion opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CHLOROMYCETIN HYDROCORTISONE offers limited career growth opportunities given its mature, LOE-approaching lifecycle and minimal linked job openings. Roles focus on maintenance and defensive market management rather than innovation or expansion.
Brand ManagerField Sales Representative
Worked on CHLOROMYCETIN HYDROCORTISONE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.